Critical role of endothelium in sustained arterial contraction during prolonged hypoxia

Am J Physiol. 1995 Mar;268(3 Pt 2):H1015-20. doi: 10.1152/ajpheart.1995.268.3.H1015.

Abstract

Acute anoxia or severe hypoxia causes an initial transient contraction followed by marked relaxation of vascular tissues. We observed a spontaneous gradual sustained contraction of rat aortic rings following relaxation when hypoxia was prolonged. Deendothelialization as well as treatment of the endothelium-intact rings with nitric oxide synthase inhibitors or oxyhemoglobin abolished the late hypoxic contraction despite prolonged hypoxia. The prolonged hypoxia-induced sustained contraction was not affected by adenosine receptor blockade, cyclooxygenase inhibition, free radical scavengers, or the endothelin receptor antagonists. The ATP-sensitive K+ channel blocker glibenclamide abbreviated the duration of hypoxic relaxation and potentiated the magnitude of late hypoxic contraction. These data suggest that the late-sustained hypoxic contraction of arterial tissues is dependent on the presence of intact functional endothelium. Activation of ATP-sensitive K+ channels may participate in the genesis of hypoxic relaxation. However, cyclooxygenase products, free oxygen radicals, adenosine, and endothelin are not involved in the regulation of hypoxia-mediated events in rat aortic rings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Amino Acid Oxidoreductases / antagonists & inhibitors
  • Animals
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / physiopathology
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology*
  • Glyburide / pharmacology
  • Hypoxia / physiopathology*
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Nitric Oxide Synthase
  • Nitroarginine
  • Oxyhemoglobins / pharmacology
  • Potassium Channel Blockers
  • Potassium Channels / metabolism
  • Purinergic P1 Receptor Antagonists
  • Rats
  • Rats, Sprague-Dawley
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology*
  • Vasodilation / drug effects
  • Vasodilation / physiology
  • omega-N-Methylarginine

Substances

  • Oxyhemoglobins
  • Potassium Channel Blockers
  • Potassium Channels
  • Purinergic P1 Receptor Antagonists
  • Nitroarginine
  • omega-N-Methylarginine
  • Adenosine Triphosphate
  • Arginine
  • Nitric Oxide Synthase
  • Amino Acid Oxidoreductases
  • Glyburide
  • Indomethacin